Hologic Revises FY24 Adj EPS Outlook From $3.97-$4.12 To $4.02-$4.12 (Est $4.03), Revenue From $3.99B-$4.065B To $4B-$4.05B (Est $4.247B)
Portfolio Pulse from Benzinga Newsdesk
Hologic has updated its FY24 adjusted EPS outlook to $4.02-$4.12 from the previous range of $3.97-$4.12, aligning closely with the estimated $4.03. The company also adjusted its revenue forecast from $3.99B-$4.065B to a slightly narrower range of $4B-$4.05B, which is below the estimated $4.247B.
May 02, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Hologic has revised its FY24 earnings and revenue outlook, with adjusted EPS now expected to be in the range of $4.02-$4.12 and revenue forecasts adjusted to $4B-$4.05B.
The adjustment in Hologic's FY24 earnings and revenue outlook reflects a slight improvement in the EPS forecast but a narrowing and slightly lower revenue projection compared to previous estimates. This mixed revision could lead to a neutral short-term impact on HOLX's stock price, as the improved EPS outlook is offset by the lower revenue forecast compared to market expectations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100